<DOC>
	<DOCNO>NCT02507908</DOCNO>
	<brief_summary>The objective observational laboratory study measure correlation 5-hydroxyindolacetic acid ( 5-HIAA ) platelet rich plasma 5-HIAA 24-hours urine collection adult patient serotonin-producing neuro-endocrine tumor . Plasma urine include patient collect 5-HIAA value measure LCMS-MS analyse .</brief_summary>
	<brief_title>5-HIAA Urine Versus 5-HIAA Plasma Patients With Serotonin Producing Neuroendocrine Tumor '</brief_title>
	<detailed_description>In midgut NETs serotonin production prominent . Patients NETs produce excessive serotonin develop carcinoid syndrome . Serotonin product 'tryptophan pathway ' . Serotonin metabolize 5-hydroxyindolacetic acid ( 5-HIAA ) excrete urine . 5-HIAA 24-hour urine collection one parameter use follow patient serotonin-producing neuroendocrine tumor . This measurement disadvantage ; could stressful , collection always precisely , furthermore collection could problematic , example patient diarrhea . Since October 2013 possible , well measurement sensitivity , measure reliably 5-HIAA platelet rich plasma ( PRP ) isotope-dilution massa-spectrometer ( LCMS-MS ) . Recent publication show 5-HIAA measure PRP could additive value diagnosis follow patient serotonin-producing NET . Objective : The primary objective measure correlation 5-HIAA PRP 5-HIAA 24-hours urine collection adult patient serotonin-producing neuro-endocrine tumor . Secondary objective determine increase decrease 5-HIAA plasma associate disease progression . Study design : This observational laboratory study . Plasma urine include patient collect standard health care , select 5-HIAA 's measure LCMS-MS. Also age , sex , diagnosis clinical course patient collect medical record . Study population : In study investigator use blood urine 60 patient serotonin-producing neuro-endocrine tumor . Main study parameters/endpoints : The main endpoint study correlation 5-HIAA PRP 5-HIAA 24-hour urine collection . Secondary endpoint correlation 5-HIAA PRP course disease , determine CT-scan ( applicable ) .</detailed_description>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<criteria>In order eligible participate study , subject must meet following criterion : Serotonin platelet &gt; 5.4 nmol / 10^9 5HIAA 24hours urine &gt; 3.8 mmol/mol creatinine Adult NET patient ( age â‰¥ 18 year age ) Blood urine collection patient collect within four day Patients allow include . A potential subject meet follow criterion exclude participation study :</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>neuroendocrine tumor</keyword>
	<keyword>5-hydroxyindolacetic acid</keyword>
	<keyword>serotonin</keyword>
	<keyword>isotope-dilution massa-spectrometer</keyword>
</DOC>